NCT06495983 Dynamic Hormone Profiling and Multimodal Data Capture in Primary Aldosteronism
| NCT ID | NCT06495983 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Haukeland University Hospital |
| Condition | Mineralocorticoid Excess |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2024-06-01 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a observational study applying 24-hour microdialysis methodology to perform dynamic multisteroid adrenal hormone profiling of patients with suspected or confirmed PA. Simultaneous registration of blood pressure, tissue glucose, sleep pattern, activity level and food intake registration may be performed. The overall objective is to develop a novel, sensitive, fast and user-friendly diagnostic procedure for PA, using multimodal data capture including dynamic multisteroid hormone profiling from microdialysis fluid.
Eligibility Criteria
Inclusion criteria Age 18 to 70 years Suspected PA admitted for diagnostic saline infusion testing or confirmed PA diagnosis according to Endocrine Society criteria.. Written informed consent Exclusion criteria * Age \<18 or \> 70 years. * Pregnancy. * Known adrenal failure and/or on steroid therapy (oral, inhaled, parenteral or topical) or other interfering medication.
Contact & Investigator
Marianne Aarda Grytaas, MD PhD
PRINCIPAL INVESTIGATOR
Haukeland University Hospital
Frequently Asked Questions
Who can join the NCT06495983 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Mineralocorticoid Excess. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06495983 currently recruiting?
Yes, NCT06495983 is actively recruiting participants. Contact the research team at marianne.grytaas@helse-bergen.no for enrollment information.
Where is the NCT06495983 trial being conducted?
This trial is being conducted at Bergen, Norway.
Who is sponsoring the NCT06495983 clinical trial?
NCT06495983 is sponsored by Haukeland University Hospital. The principal investigator is Marianne Aarda Grytaas, MD PhD at Haukeland University Hospital. The trial plans to enroll 80 participants.